MXPA00003885A - Quimiocinas con modificiaciones de la terminacion amino. - Google Patents

Quimiocinas con modificiaciones de la terminacion amino.

Info

Publication number
MXPA00003885A
MXPA00003885A MXPA00003885A MXPA00003885A MXPA00003885A MX PA00003885 A MXPA00003885 A MX PA00003885A MX PA00003885 A MXPA00003885 A MX PA00003885A MX PA00003885 A MXPA00003885 A MX PA00003885A MX PA00003885 A MXPA00003885 A MX PA00003885A
Authority
MX
Mexico
Prior art keywords
chimeric polypeptides
polypeptides containing
containing chemokine
domains
chemokine domains
Prior art date
Application number
MXPA00003885A
Other languages
English (en)
Inventor
Stephen H Herrmann
Original Assignee
Inst Genetics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Genetics Llc filed Critical Inst Genetics Llc
Priority claimed from PCT/US1998/004002 external-priority patent/WO1998038212A2/en
Priority claimed from US09/175,713 external-priority patent/US6852508B1/en
Publication of MXPA00003885A publication Critical patent/MXPA00003885A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Adhesives Or Adhesive Processes (AREA)

Abstract

La invencion provee polinucleotidos que comprenden secuencias que codifican para quimiocinas modificadas con terminacion amino, las quimiocinas modificadas con terminacion amino, y los usos de las mismas.
MXPA00003885A 1997-10-22 1998-02-27 Quimiocinas con modificiaciones de la terminacion amino. MXPA00003885A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95582697A 1997-10-22 1997-10-22
PCT/US1998/004002 WO1998038212A2 (en) 1997-02-28 1998-02-27 Chimeric polypeptides containing chemokine domains
US09/175,713 US6852508B1 (en) 1997-02-28 1998-10-20 Chemokine with amino-terminal modifications

Publications (1)

Publication Number Publication Date
MXPA00003885A true MXPA00003885A (es) 2004-04-23

Family

ID=56289826

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA00003885A MXPA00003885A (es) 1997-10-22 1998-02-27 Quimiocinas con modificiaciones de la terminacion amino.

Country Status (5)

Country Link
EP (1) EP1025229A4 (es)
JP (1) JP2003526315A (es)
AU (1) AU758576C (es)
MX (1) MXPA00003885A (es)
WO (1) WO1999020759A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998024923A1 (en) * 1996-12-02 1998-06-11 Wake Forest University Inactivation of hiv co-receptors as therapy for hiv infection
US6645491B1 (en) 1999-02-03 2003-11-11 Schering Corporation Method for treating inflammatory conditions using an antibody to MIP-3α
CA2362091A1 (en) * 1999-02-03 2000-08-10 Schering Corporation Use of agonists or antagonists of mip-3a in therapy
CA2389979C (en) * 1999-11-24 2011-08-16 Schering Corporation Methods of inhibiting metastasis
US7091310B2 (en) * 2002-09-13 2006-08-15 Chemokine Therapeutics Corporation Chemokine analogs for the treatment of human disease
DE10027383A1 (de) * 2000-06-02 2001-12-20 Rhein Biotech Proz & Prod Gmbh Nukleinsäure-Molekül umfassend eine für ein Chemokin, einen Neuropeptid-Präkursor oder mindestens ein Neuropeptid kodierende Nukleinsäuresequenz
KR20030032977A (ko) * 2000-07-12 2003-04-26 그리폰 테라퓨틱스, 인코포레이티드 키모카인 수용체 조절제, 제조 및 사용
WO2002010138A2 (en) * 2000-08-01 2002-02-07 Schering Corporation Uses of mammalian genes and related reagents
US20020114806A1 (en) * 2000-09-13 2002-08-22 Annie Pardo-Semo Uses of mammalian genes and related reagents
AU2002235168A1 (en) * 2000-11-05 2002-05-15 University Of Florida Targeting pluripotent stem cells to tissues
WO2003024404A2 (en) * 2001-09-20 2003-03-27 Schering Corporation Chemokines as adjuvants of immune response
US20050271639A1 (en) * 2002-08-22 2005-12-08 Penn Marc S Genetically engineered cells for therapeutic applications
WO2004094465A2 (en) * 2003-04-23 2004-11-04 The Board Of Trustees Of The University Of Illinois Office Of Technology Management University Of Illinois At Urbana-Champaign Synthetic molecules that mimic chemokines
EP2142206B1 (en) 2007-03-30 2014-07-30 The Cleveland Clinic Foundation SDF-1 for use in the treatment of ischemic peripheral vascular disorders
AU2008317495B2 (en) 2007-08-02 2013-08-01 Novimmune S.A. Anti-RANTES antibodies and methods of use thereof
US20100272679A1 (en) 2007-12-14 2010-10-28 Penn Marc S Compositions and methods of promoting wound healing
CA2772610C (en) 2009-08-28 2018-01-23 The Cleveland Clinic Foundation Sdf-1 delivery for treating ischemic tissue
KR20210081372A (ko) * 2018-10-22 2021-07-01 유니버시티 오브 피츠버그 - 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 절단 가능한 cxcr3의 활성제 및 이의 사용 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656456A (en) * 1992-07-13 1997-08-12 Bionebraska, Inc. Chemical method for selective modification of the N- and/or C-terminal amino acid α-carbon reactive group of a recombinant polypeptide or a portion thereof
JP3367581B2 (ja) * 1993-10-14 2003-01-14 小野薬品工業株式会社 新規なポリペプチド、その製造方法、そのポリペプチドをコードするｄｎａ、そのｄｎａからなるベクター、そのベクターで形質転換された宿主細胞
CN1087346C (zh) * 1994-12-08 2002-07-10 格拉克索公司 用于炎症治疗的rantfs肽和片段及包括它们的组合物
AU728512B2 (en) * 1996-04-02 2001-01-11 Progenics Pharmaceuticals, Inc. Method for preventing HIV-1 infection of CD4+ cells
FR2751658B1 (fr) * 1996-07-26 1998-10-02 Pasteur Institut Utilisation d'une chemokine (sdf-1) ligand pour le recepteur de lestr/fusin/cxcr4 pour prevenir ou traiter l'infection par des virus de type vih

Also Published As

Publication number Publication date
JP2003526315A (ja) 2003-09-09
WO1999020759A1 (en) 1999-04-29
EP1025229A1 (en) 2000-08-09
AU758576B2 (en) 2003-03-27
EP1025229A4 (en) 2003-06-18
AU758576C (en) 2004-04-29
AU1110599A (en) 1999-05-10

Similar Documents

Publication Publication Date Title
WO1998038212A3 (en) Chimeric polypeptides containing chemokine domains
MXPA00003885A (es) Quimiocinas con modificiaciones de la terminacion amino.
WO2001053312A8 (en) Novel nucleic acids and polypeptides
WO2001053455A3 (en) Novel nucleic acids and polypeptides
HK1013847A1 (en) Gdf-1 and uog-1 proteins
NZ335485A (en) Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
HK1040401A1 (en) Isolated nucleic acid molecules which encode t cell inducible factors (tifs), the proteins encoded, and uses thereof
IL131030A0 (en) Receptor that binds trail
ZA988392B (en) Tie ligand homologues.
WO2001075067A3 (en) Novel nucleic acids and polypeptides
WO2001057188A3 (en) Novel nucleic acids and polypeptides
WO2001057190A3 (en) Novel nucleic acids and polypeptides
WO2002022660A3 (en) Novel nucleic acids and polypeptides
WO2001066689A3 (en) Novel nucleic acids and polypeptides
WO2002031111A3 (en) Novel nucleic acids and polypeptides
AU3274995A (en) Fibrin-binding peptides, dna coding therefor and uses thereof
WO2001088088A3 (en) Novel nucleic acids and polypeptides
WO2002059260A3 (en) Nucleic acids and polypeptides
HK1030613A1 (en) Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest
IL132496A0 (en) Mammalian cytokine-like factor 7
ZA9710288B (en) Novel genes encoding telomerase proteins.
WO2002018424A3 (en) Nucleic acids and polypeptides
WO2001079449A3 (en) Novel nucleic acids and polypeptides
DE69841176D1 (en) Rtd receptor
EP0692532A4 (en) NOVEL POLYPEPTIDE, DNA ENCODING SAID POLYPEPTIDE, RECOMBINATION VECTOR CONTAINING SAID DNA, RECOMBINATION VIRUS PREPARED BY SAID VECTOR, AND USE OF SAID VIRUS